What is March outlook for Cabot (USA Stocks:CBT)?

Cabot is scheduled to announce its earnings today. Because some millenniums are getting more into chemicals space, we are going to review the feasibility of inclusion Cabot into your portfolio. We will evaluate why recent Cabot price moves suggest a bounce in March.
Published over a year ago
View all stories for Cabot | View All Stories
Macroaxis uses a strict editorial review process to publish stories and blog posts. Our publishers support our company and may receive a small commission when the partner links or references are utilized. Commissions do not affect the opinions or evaluations of our editorial team. The information our editors and media partners deliver is confidential and licensed for your sole use as a Macroaxis user. We reserve all rights to the content of this article, and therefore copying or distributing this story in whole or in part is strictly prohibited.

Reviewed by Michael Smolkin

The company has 1.09 B in debt with debt to equity (D/E) ratio of 1.4, which is OK given its current industry classification.
What is the right price you would pay to acquire a share of Cabot? For most investors, it would be the price that gives them a wide margin of safety to have minimal downside risk. In other words, most investors are always looking for undervalued stocks. Even if the future performance is not entirely as expected, the loss of holding it is minimized, and the downside risk is negated. Please read more on our stock advisor page.

What is happening with Cabot this year

Annual and quarterly reports issued by Cabot are formal financial statements that are published yearly and quarterly and sent to Cabot stockholders. The reports show and break down the current year's ongoing operations and discuss plans for the upcoming year. Annual reports have been a requirement from the Securities and Exchange Commission (SEC) for businesses owned by the public since 1934.
Companies such as Cabot often view their annual report as an effective marketing tool to disseminate their perspective on company future earnings or innovations. With this in mind, many companies devote large sums of money to making their reports attractive and informative. In such instances, the annual report becomes a forum through which a company can communicate to the general public any number of topics that may or may not be directly related to the actual data published in the reports.

Cabot Gross Profit

Cabot Gross Profit growth is one of the most critical measures in evaluating the company. The Gross Profit growth rate is calculated simply by comparing Cabot previous period's values with its current period's values. Each time period you're measuring should be of equal lengths the increase or decrease, in a company's Gross Profit between two periods. Here we show Cabot Gross Profit growth over the last 10 years. Please check Cabot's gross profit and other fundamental indicators for more details.

Is Cabot a risky opportunity?

Let's check the volatility. Cabot is looking slightly risky at this time. Whether you invest your money or manage your clients' funds, remember that it is easy to forget that behind Cabot (USA Stocks:CBT) stock is an actual business venture. So, do not let stock picking become an abstract concept by ignoring the elementary risk calculations. acquiring a share of a Cabot stock makes you a part-owner of that company.

Cabot Current Consensus

Here is the newest trade recommendation based on an ongoing consensus estimate among financial analysis covering Cabot. The Cabot consensus assessment is calculated by taking the average estimates from all of the analysts covering Cabot
Strong Buy
6
Hold
1
Strong Buy685.71
Buy00.0
Hold114.29
Sell00.0
Strong Sell00.0

Another small drop for Cabot

Semi deviation is down to 2.44. It may call for a possible volatility drop.
As of the 9th of February, Cabot shows the mean deviation of 1.9, and Risk Adjusted Performance of 0.0406. Cabot technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We have analyzed nineteen technical drivers for Cabot, which can be compared to its rivals. Please confirm Cabot coefficient of variation, as well as the relationship between the treynor ratio and semi variance to decide if Cabot is priced correctly, providing market reflects its regular price of 73.26 per share. Given that Cabot has jensen alpha of (0.08), we suggest you to validate Cabot's prevailing market performance to make sure the company can sustain itself at a future point.

Our Final Take On Cabot

When is the right time to buy or sell Cabot? Buying stocks such as Cabot isn't very hard. However, what challenging for most investors is doing it at the right time. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities, deliver winning trades and diversify portfolios on a daily basis.
To conclude, as of the 9th of February 2023, our concluding 90 days recommendation on the firm is Strong Buy. We believe Cabot is fairly valued with below average chance of financial distress for the next two years.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Editorial Staff

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Ellen Johnson do not own shares of Cabot. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com